PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

Pathway Diagram

flowchart TD
    PIK3C3["PIK3C3"]
    style PIK3C3 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    Sertoli_Cell["Sertoli Cell"]
    PIK3C3 -->|"expressed in"| Sertoli_Cell
    AUTOPHAGY["AUTOPHAGY"]
    PIK3C3 -->|"regulates"| AUTOPHAGY
    autophagy["autophagy"]
    PIK3C3 -->|"activates"| autophagy
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    PIK3C3 -->|"associated with"| PARKINSON_S_DISEASE
    Sertoli_Cell_Polarity["Sertoli Cell Polarity"]
    PIK3C3 -->|"regulates"| Sertoli_Cell_Polarity
    SCIN["SCIN"]
    PIK3C3 -->|"associated with"| SCIN
    PIK3C3 -->|"associated with"| Sertoli_Cell
    Autophagy["Autophagy"]
    PIK3C3 -->|"regulates"| Autophagy
    BECN1["BECN1"]
    BECN1 -->|"associated with"| PIK3C3
    Spautin_1["Spautin-1"]
    Spautin_1 -->|"associated with"| PIK3C3
    CLU["CLU"]
    CLU -->|"activates"| PIK3C3
    BRSK2["BRSK2"]
    BRSK2 -->|"associated with"| PIK3C3
    SRSF1["SRSF1"]
    SRSF1 -->|"binds"| PIK3C3
    style Sertoli_Cell fill:#006494,stroke:#888,color:#e0e0e0
    style AUTOPHAGY fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style autophagy fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style PARKINSON_S_DISEASE fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style Sertoli_Cell_Polarity fill:#ef5350,stroke:#ff8a65,color:#e0e0e0
    style SCIN fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style Autophagy fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style BECN1 fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style Spautin_1 fill:#006494,stroke:#4fc3f7,color:#e0e0e0
    style CLU fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style BRSK2 fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style SRSF1 fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0

Overview

PIK3C3 (Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3), also known as VPS34 (Vacuolar Protein Sorting 34), is the catalytic subunit of the class III phosphatidylinositol 3-kinase (PI3K-III) complex. As the sole class III PI3K in mammals, PIK3C3/VPS34 plays an indispensable role in regulating autophagy—the cellular process for degrading and recycling damaged organelles, protein aggregates, and intracellular pathogens. PIK3C3 catalyzes the phosphorylation of phosphatidylinositol (PI) to generate phosphatidylinositol 3-phosphate (PI3P), a lipid essential for autophagosome formation, endosomal trafficking, and lysosomal function^{1VPS34 in autophagy and neurodegeneration2020 · Cell · DOI 10.1016/j.cell.2020.03.015Open reference}.

The significance of PIK3C3 in neurodegeneration cannot be overstated. Loss of PIK3C3 activity leads to catastrophic neuronal dysfunction, as demonstrated by mouse models where neural-specific deletion of PIK3C3 causes profound neurodegeneration, accumulation of protein aggregates, and early death. In human neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and other disorders, PIK3C3-mediated autophagy is consistently impaired, contributing to the accumulation of toxic protein aggregates that define these conditions^{2PIK3C3 and lysosomal function2019 · Nature Reviews Molecular Cell Biology · DOI 10.1038/s41580-019-0151-3Open reference}. Understanding PIK3C3 function offers therapeutic opportunities for enhancing cellular clearance mechanisms in these devastating disorders.

Gene and Protein Structure

Gene Information

Protein Structure

The PIK3C3 protein (887 amino acids, ~100 kDa) contains:

1. N-terminal C2 Domain (aa 1-120): Membrane targeting, calcium-independent phospholipid binding

2. Rash Helical Domain (aa 120-280): Regulatory interactions

3. Kinase Domain (aa 280-650): Catalytic activity, ATP binding

4. C-terminal Region (aa 650-887): Protein-protein interactions, regulatory functions

PIK3C3 Complexes

PIK3C3 functions in multiple distinct complexes^{3Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg142012 · Molecular Biology of the Cell · DOI 10.1091/mbc.E11-09-0847Open reference}:

Core Autophagy Complex (PI3K-C1):

• PIK3C3 (VPS34) — catalytic subunit

• PIK3R4 (VPS15/p150) — regulatory subunit

• BecLIN1 — essential for autophagy

• ATG14L/Barkor — autophagy-specific

Endosomal/Trafficking Complex (PI3K-C2):

• PIK3C3 (VPS34)

• PIK3R4 (VPS15)

• BecLIN1

• UVRAG — endosome function

• RUBICON — negative regulation

Biochemical Function

Lipid Kinase Activity

PIK3C3 catalyzes^{4The role of Atg proteins in autophagosome formation2018 · Annual Review of Cell and Developmental Biology · DOI 10.1146/annurev.cellbio.041308.093801Open reference}:

Phosphatidylinositol + ATP → Phosphatidylinositol 3-phosphate + ADP

The product PI3P is enriched on:

• Inner autophagosomal membrane

• Endosomal membranes

• Phagophore assembly site (PAS)

Autophagy Initiation

PI3P generation is essential for

Phagophore Formation:

• Recruitment of ATG proteins

• Membrane expansion

• Cargo recognition

Autophagosome Maturation:

• Closure of double-membrane vesicle

• LC3 lipidation and incorporation

• Cargo loading

ATGs Recruited by PI3P:

• DFCP1 (double FYVE domain-containing protein 1)

• WIPI1/2 (WD repeat domain phosphoinositide-interacting)

• ATG16L1 complex

Endosomal Function

Beyond autophagy, PIK3C3 regulates^{5The Beclin 1-VPS34 complex regulates autophagy2010 · Cell Research · DOI 10.1038/cr.2010.38Open reference}:

• Early endosome maturation

• Endosomal trafficking

• Late endosome-lysosome fusion

• Phagocytosis

Role in Neurodegeneration

Alzheimer’s Disease

PIK3C3 and autophagy are significantly impaired in AD^{6Autophagy in Alzheimer's disease2021 · Nature Reviews Neurology · DOI 10.1038/s41582-021-00456-2Open reference7Endolysosomal dysfunction in Alzheimer's disease2021 · Nature Reviews Neuroscience · DOI 10.1038/s41583-021-00467-3Open reference}:

Autophagy Dysfunction:

• Reduced PIK3C3 activity in AD brains

• Impaired autophagosome formation

• Accumulation of autophagic vacuoles

• Failed cargo clearance

Amyloid Processing:

• Autophagy regulates APP trafficking

• Autophagy contributes to Aβ generation

• Impaired autophagy increases extracellular Aβ

• PIK3C3 activation reduces amyloid burden

Tau Pathology:

• Autophagy degrades phosphorylated tau

• PIK3C3 dysfunction leads to tau accumulation

• Autophagic-lysosomal pathway impairment

• Tau propagation through exosomes

Synaptic Dysfunction:

• Autophagy maintains synaptic homeostasis

• Impaired autophagy in AD synapses

• Synaptic protein aggregation

• Memory consolidation defects

Endolysosomal Dysfunction:

• PIK3C3 essential for lysosomal function

• Lysosomal impairment in AD

• Cathepsin activation failure

• Amyloid and tau clearance blocked

Parkinson’s Disease

PIK3C3 is directly implicated in PD pathogenesis^{8Autophagy-lysosome pathway in PD2020 · Neurobiology of Aging · DOI 10.1016/j.neurobiolaging.2020.04.012Open reference9PIK3C3/VPS34 in Parkinson's disease and LRRK2 pathway2020 · Molecular Neurodegeneration · DOI 10.1186/s13024-020-00393-5Open reference}:

LRRK2 Connection:

• LRRK2 mutations are common in familial PD

• LRRK2 phosphorylates PIK3C3/VPS34

• LRRK2 G2019S enhances PIK3C3 inhibition

• Dysregulated autophagy in LRRK2 models

Alpha-synuclein Clearance:

• Autophagy degrades α-synuclein

• PIK3C3 inhibition leads to α-syn accumulation

• Autophagic-lysosomal pathway in Lewy bodies

• Exosomal release of α-syn

Dopaminergic Neuron Vulnerability:

• High basal autophagy requirement

• PIK3C3 impairment in substantia nigra

• Mitochondrial quality control failure

• Progressive dopaminergic degeneration

PINK1/Parkin Pathway:

• Mitophagy requires PIK3C3 function

• Impaired mitophagy in PD

• Damaged mitochondria accumulation

• Apoptotic neuron death

Therapeutic Potential:

• PIK3C3 activators protect dopaminergic neurons

• Autophagy enhancement reduces α-syn toxicity

• Combination with LRRK2 inhibitors

Other Neurodegenerative Conditions

PIK3C3 dysfunction contributes to:

Huntington’s Disease:

• Mutant huntingtin impairs autophagy

• Autophagy decline with disease progression

• PIK3C3 as therapeutic target

Amyotrophic Lateral Sclerosis:

• Autophagy impairment in motor neurons

• Aggregate clearance failure

• SOD1 aggregate accumulation

Frontotemporal Dementia:

• Tau and TDP-43 aggregation

• Autophagy pathway dysfunction

Neuronal Functions

Autophagy in Neurons

Neurons rely heavily on autophagy due to^{10Loss of autophagy in the central nervous system causes neurodegeneration2007 · Nature · DOI 10.1038/nature05925Open reference2PIK3C3 and lysosomal function2019 · Nature Reviews Molecular Cell Biology · DOI 10.1038/s41580-019-0151-3Open reference}0:

Post-mitotic Nature:

• No cell division to dilute aggregates

• Must maintain protein homeostasis indefinitely

• High metabolic demands

Axonal Transport:

• Autophagosomes formed in distal axons

• Retrograde transport to soma

• Lysosomal degradation

Synaptic Function:

• Continuous protein turnover

• Synaptic vesicle recycling

• Activity-dependent autophagy

Synaptic Plasticity

PIK3C3/VPS34 regulates^{2PIK3C3 and lysosomal function2019 · Nature Reviews Molecular Cell Biology · DOI 10.1038/s41580-019-0151-3Open reference}1:

• Synaptic vesicle endocytosis

• Synaptic vesicle recycling

• Vesicle pool maintenance

• Activity-induced autophagy

Cellular Homeostasis

PIK3C3 maintains neuronal health through:

Protein Quality Control:

• Aggregate clearance

• Mitochondrial turnover (mitophagy)

• ER quality control

• Ribophagy (ribosome degradation)

Organelle Maintenance:

• Mitochondrial dynamics

• Lysosomal function

• Peroxisome turnover

Stress Response:

• Nutrient stress adaptation

• Oxidative stress response

• Proteotoxic stress management

Autophagy Pathway Connections

Initiation

The autophagy cascade^{2PIK3C3 and lysosomal function2019 · Nature Reviews Molecular Cell Biology · DOI 10.1038/s41580-019-0151-3Open reference}2:

mTORC1 inhibition → ULK1 activation → ATG14L complex →
PIK3C3 activation → PI3P production → Autophagosome formation

PIK3C3 sits at the critical step of PI3P production.

Maturation

PIK3C3-generated PI3P mediates:

• LC3 lipidation (ATG4, ATG7, ATG3)

• ATG12-ATG5 conjugate formation

• Autophagosome-lysosome fusion

• Cargo selection via p62/SQSTM1

Degradation

• Lysosomal fusion

• Acidification

• Cathepsin activation

• Cargo breakdown

• Nutrient recycling

Disease Associations

Therapeutic Targeting

Activation Strategies

Small Molecule Activators:

• PIK3C3-specific activators in development

• Indirect activators via mTOR inhibition

• Autophagy-inducing compounds

Gene Therapy:

• PIK3C3 overexpression

• Beclin1 enhancement

• ATG gene upregulation

Challenges

• Specificity: PIK3C3 has multiple functions

• BBB Penetration: CNS delivery required

• Therapeutic Window: Overactivation may be harmful

• Timing: Disease stage matters

Combination Approaches

• With amyloid-targeting therapies (AD)

• With LRRK2 inhibitors (PD)

• With anti-inflammatory treatments

• With mitochondrial protectants

Expression Patterns

Brain Expression

PIK3C3 is widely expressed in:

• Neurons (high in hippocampus, cortex)

• [Astrocytes](/cell-type- Oligodendrocytesoglia

• Oligodendrocytes

Subcellular Localization

• Cytoplasmic (diffuse)

• Endosomal membranes

• Autophagosomes

• Lysosomes (low levels)

Regulation

PIK3C3 activity is regulated by:

• mTORC1 (inhibition)

• AMPK (activation during stress)

• Beclin1 binding

• Phosphorylation (multiple sites)

Research Directions

Biomarkers

• PIK3C3 activity in CSF

• PI3P levels as readouts

• Autophagic flux measurements

Mechanisms

• Cell type-specific functions

• In vivo imaging of autophagy

• Circuit-specific roles

Clinical Translation

• PIK3C3 modulators in trials

• Autophagy enhancement strategies

• Personalized approaches

Summary

PIK3C3 (VPS34) is the catalytic subunit of class III PI3K, essential for generating PI3P that drives autophagosome formation, endosomal trafficking, and lysosomal function. As the central regulator of cellular clearance pathways, PIK3C3 is critical for maintaining neuronal homeostasis by clearing protein aggregates, damaged mitochondria, and other cellular debris. In Alzheimer’s disease, PIK3C3 dysfunction contributes to amyloid and tau accumulation through impaired autophagic-lysosomal pathways. In Parkinson’s disease, PIK3C3 inhibition by mutant LRRK2 and impaired mitophagy lead to alpha-synuclein accumulation and dopaminergic neuron death. The fundamental importance of PIK3C3 in neurodegeneration makes it a compelling therapeutic target, though achieving specific activation without disrupting normal cellular functions remains challenging. Enhancing PIK3C3-mediated autophagy represents a promising strategy for treating these devastating disorders.